Tue.Mar 25, 2025

article thumbnail

Addressing Burnout in Pharmacy | APhA 2025

Drug Topics

Alisha Reed, PharmD, founder of Your Self Care Prescription, LLC, discussed how pharmacists can implement wellness programs to reduce burnout.

407
407
article thumbnail

The industry heavyweight behind Novavax’s push to bounce back

PharmaVoice

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Vaccines 284
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacists’ Role in Addressing Vaccine Barriers Among Underserved Communities | APhA 2025

Drug Topics

Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.

Vaccines 363
article thumbnail

Opinion: 23andMe’s bankruptcy doesn’t diminish its impact

STAT

23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.

116
116
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Q&A: How Pharmacists Can Make a Difference Beyond the Counter

Drug Topics

Jade Ranger, co-owner and pharmacist of the Prescription Shoppe, discusses how her pharmacy put patients first during the COVID-19 pandemic.

341
341
article thumbnail

How long does it take bupropion to work?

The Checkup by Singlecare

Bupropion , commonly marketed under the brand names Wellbutrin SR, Wellbutrin XL, and Zyban, is an oral medication used for treating adult depression and seasonal affective disorder (SAD). SAD is a form of depression that occurs in a recurrent seasonal pattern and is more common or severe during winter. Bupropion is also approved by the Food and Drug Administration (FDA) as a medication for aiding smoking cessation.

Dosage 59

More Trending

article thumbnail

Is my Pharma Marketing Job Going to Be Eliminated?

Pharma Marketing Network

Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.

59
article thumbnail

Potential Challenges in Using ChatGPT for Pharmacy Services

Drug Topics

With the rise of large-language models like ChatGPT, pharmacists must know the potential challenges they may encounter when using these new technologies.

247
247
article thumbnail

Biogen plots new global headquarters in Kendall Square

PharmaVoice

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

130
130
article thumbnail

FDA Approves Gepotidacin for Uncomplicated UTI

Drug Topics

The decision makes the therapy the first oral antibiotic treatment approved for uUTIs in over 20 years.

FDA 242
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How to Become a Medical Affairs Specialist [Career Path Guide]

The Happy PharmD

Pharmacists who want to break into medical affairs often feel stuck. They know they want a change, but theyre unsure how to make the transitionespecially when they have zero industry experience. But heres the thing: you dont need to start over. You dont need another degree. And you dont need years of industry work under your belt. Vincent had the same doubts.

article thumbnail

Expert Discusses Changes in Diabetes Care | APhA 2025

Drug Topics

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, discusses recent advancements in diabetes care.

190
190
article thumbnail

Healthcare Business Intelligence (BI): Comprehensive Guide

Viseven

There is one thing that can completely change how healthcare organizations approach their patients. It’s data. And one of the best ways to manage and use it for insights is business intelligence. In healthcare, business intelligence tools play a far more critical role than might initially seem. These tools often hold the key to solving challenges and addressing the situations, where timely access to data is paramount.

article thumbnail

Pharmacy Owner Highlights Experiences With Misinformation During COVID-19 Pandemic

Drug Topics

In the evolving landscape of community pharmacy, the Prescription Shoppe emerged as a beacon of resilience and patient-centered care during the COVID-19 pandemic.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Educate Patients About How PBMs’ Vertical Integration Impacts Their Health Care

Pharmacy Times

Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicatedand often leaves patients footing the bill.

114
114
article thumbnail

How Pharmacists Can Support Adherence Among Patients Using GLP-1s

Drug Topics

Lydia Newsom, PharmD, discusses how to support patients who are struggling with injection techniques or gastrointestinal side effects of GLP-1s.

190
190
article thumbnail

Are COVID vaccines still free?

The Checkup by Singlecare

During the COVID-19 pandemic, broad immunization was key, so the Centers for Disease Control and Prevention (CDC) provided funding for free vaccines. But since then, the COVID-19 virus has evolved and new boosters have helped prevent different variants. Yet in 2023, federal funding ceased. That means people had to rely on their insurance plan for coverage.

article thumbnail

Gepotidacin Receives FDA Approval for uUTIs in Adult, Pediatric Female Patients

Pharmacy Times

Gepotidacin is indicated for female patients who are at least 12 years of age and weigh at least 40 kg with uncomplicated urinary tract infections (uUTIs) caused by certain microorganisms.

FDA 108
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA starts review of Sanofi's MS hope tolebrutinib

pharmaphorum

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis

FDA 101
article thumbnail

How much is lacosamide without insurance?

The Checkup by Singlecare

Lacosamidealso known as Vimpatis a generic prescription drug that is used to treat partial-onset seizures in adults and children ages 4 years and older. It can also be prescribed with other drugs to treat primary generalized tonic-clonic seizures. Without insurance, the average retail price of lacosamide is $1,067 for 60, 100 mg tablets. While there arent any over-the-counter alternatives, there are other ways to reduce the price of a lacosamide prescription.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Spending on GLP-1 drugs continues to rise, and outpaced trends in other specialty drugs for the first time in 2023, according to a new report from Evernorth.

97
article thumbnail

First Antibody Therapy for Acute Myocardial Infarction Granted FDA Fast Track Designation

Pharmacy Times

If approved, this novel monoclonal antibody therapy could become a standard of care emergency option for patients with acute myocardial infarction, which affects millions in the United States and across the world.

FDA 89
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Though the genetic testing company is still operating under California's stricter consumer data privacy standards, uncertainty over a new owner's policies, security risks through the court bidding process and inconsistent protections elsewhere in the country have customers and privacy advocates on edge.

88
article thumbnail

Introducing the Tell-Tale Heart Podcast

Pharmacy Times

This new podcast will explore the latest evidence, practices, and innovations in the world of cardiovascular care from a pharmacist's point of view.

83
article thumbnail

Does the kidney transplant system need to change?

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! It was quite a rainy day in Boston yesterday — but at least it wasn’t a cold one. I’m manifesting some sun for today.

80
article thumbnail

Pharmacists Are Key Players in C difficile Infection Prevention

Pharmacy Times

Pharmacists can promote prevention through the implementation of antimicrobial stewardship initiatives and advocate for fecal microbiota transplant.

82
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

In a new assessment, the Peterson Health Technology Institute finds mixed reviews on key metrics for ambient scribes. While scribes clearly reduced cognitive load for physicians, they don't uniformly reduce pajama time or produce financial returns.

79
article thumbnail

Ochsner Children’s and ISMP launch pharmacy fellowship

Pharmacy Times

Nations first ISMP medication safety fellowship shared with a healthcare provider.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Navina's AI copilot for clinicians surfaces patient insights at the point of care to augment clinician understanding of structured and unstructured data. The company's total funding to date is $100M.

75
article thumbnail

COVID-19 5 Years Later: The Impact on Drug Discovery

Pharmacy Times

As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Arlo, a level-funded health plan and underwriting tech company for small businesses, has locked down $4 million from three venture capital groups and angel investors. | Arlo, a startup insurer, will use the funds to expand its team and further differentiate itself from BUCAH carriers and rival startups.

article thumbnail

APhA 2025: Developing Leadership Skills in Pharmacy Technician Practice

Pharmacy Times

Pharmacy technicians can elevate their careers by developing leadership skills, pursuing specialized certifications, and embracing continuous professional growth.

65
article thumbnail

UK weight loss market: M&A opportunities

pharmaphorum

Explore the latest M&A opportunities in the UK weight loss market, including market access for products like Wegovy and Mounjaro. Stay informed about key trends and opportunities in the industry.

64